Narmada Gelatines Q4 FY26: Stellar Margin Expansion Drives 69% Profit Surge

May 25 2026 10:20 PM IST
share
Share Via
Narmada Gelatines Ltd., a micro-cap speciality chemicals manufacturer, delivered a spectacular fourth quarter performance for FY26, with consolidated net profit surging 69.32% year-on-year to ₹10.21 crores, significantly outpacing market expectations. The Jabalpur-based gelatine and ossein producer demonstrated remarkable operational efficiency, with operating margins expanding to a multi-quarter high of 22.30%, reflecting strong pricing power and effective cost management.
Narmada Gelatines Q4 FY26: Stellar Margin Expansion Drives 69% Profit Surge
Consolidated Net Profit (Q4 FY26)
₹10.21 Cr
▲ 69.32% YoY | ▲ 21.55% QoQ
Net Sales (Q4 FY26)
₹61.70 Cr
▲ 23.97% YoY | ▲ 8.76% QoQ
Operating Margin (Q4 FY26)
22.30%
▲ 730 bps YoY | ▲ 349 bps QoQ
Return on Equity (Latest)
19.40%
Strong capital efficiency

The company, with a market capitalisation of ₹243.00 crores, witnessed its stock price rally 9.41% to ₹439.70 following the results announcement, reflecting strong investor confidence in the company's operational turnaround. Trading volumes surged to 77,634 shares, substantially above recent averages, as the stock touched an intraday high of ₹460.00—matching its 52-week peak.

The quarterly results represent a continuation of an impressive growth trajectory that began in the second half of FY25. Revenue growth accelerated to 23.97% year-on-year, whilst sequential growth remained robust at 8.76%, marking the fourth consecutive quarter of double-digit top-line expansion. More importantly, the company achieved this growth whilst simultaneously expanding margins, suggesting strong underlying demand and favourable industry dynamics.

Financial Performance: Margin Expansion Story Takes Centre Stage

Narmada Gelatines' Q4 FY26 financial performance was characterised by exceptional margin expansion across all profitability metrics. Net sales for the quarter stood at ₹61.70 crores, representing the highest quarterly revenue in the company's recent history. The 23.97% year-on-year growth significantly outpaced the company's five-year sales CAGR of 9.54%, indicating accelerating business momentum.

The standout feature of the quarter was the dramatic improvement in operating margins. Operating profit (PBDIT excluding other income) surged to ₹13.76 crores, translating to a margin of 22.30%—up from 15.01% in Q4 FY25 and 18.81% in Q3 FY26. This 730 basis points year-on-year margin expansion reflects a combination of favourable product mix, pricing power, and operational efficiencies. Employee costs remained well-controlled at ₹4.75 crores, representing just 7.70% of sales, down from 8.50% in the year-ago quarter.

Quarter Net Sales (₹ Cr) QoQ Growth YoY Growth Operating Margin PAT (₹ Cr) PAT Margin
Mar'26 61.70 +8.76% +23.97% 22.30% 10.21 16.55%
Dec'25 56.73 +10.78% +18.14% 18.81% 8.40 14.81%
Sep'25 51.21 +11.89% 18.26% 6.89 13.45%
Jun'25 45.77 -8.04% 16.43% 5.98 13.07%
Mar'25 49.77 +3.64% 15.01% 6.03 12.12%
Dec'24 48.02 13.70% 4.42 9.20%

Profit before tax (PBT) for Q4 FY26 reached ₹13.32 crores, up 83.21% year-on-year, with the company benefiting from reduced interest costs. Interest expense declined to ₹0.29 crores from ₹0.36 crores in the year-ago quarter, reflecting improved financial leverage. The effective tax rate for the quarter stood at 23.35%, slightly above the previous quarter's 22.08% but below the company's average tax rate of 24.55%.

Net profit after tax (standalone) came in at ₹9.58 crores, whilst consolidated PAT—which includes subsidiary contributions—stood at ₹10.21 crores. The PAT margin expanded to 16.55% from 12.12% in Q4 FY25, representing a remarkable 443 basis points improvement. This margin expansion, achieved alongside robust volume growth, underscores the high operating leverage inherent in the company's business model.

Revenue (Q4 FY26)
₹61.70 Cr
▲ 23.97% YoY | ▲ 8.76% QoQ
Consolidated PAT (Q4 FY26)
₹10.21 Cr
▲ 69.32% YoY | ▲ 21.55% QoQ
Operating Margin (Q4 FY26)
22.30%
Multi-quarter high
PAT Margin (Q4 FY26)
16.55%
▲ 443 bps YoY

Operational Excellence: Capital Efficiency Reaches New Heights

Beyond the headline numbers, Narmada Gelatines demonstrated exceptional capital efficiency during Q4 FY26. The company's return on equity (ROE) surged to 19.40% for the latest period, significantly above its five-year average of 12.68% and well ahead of most peers in the speciality chemicals sector. This elevated ROE reflects not only improved profitability but also efficient deployment of shareholder capital.

The company's return on capital employed (ROCE) stood at an impressive 20.86% for the latest period, substantially higher than the five-year average of 15.29%. Higher ROCE indicates that the company is generating superior returns on the capital invested in its operations, a critical metric for assessing management efficiency and competitive positioning. The company's average EBIT to interest coverage ratio of 19.30 times provides substantial cushion against financial stress, whilst the debt-to-EBITDA ratio of just 0.63 times indicates conservative financial leverage.

Key Strength: Superior Capital Efficiency

Narmada Gelatines' ROE of 19.40% places it amongst the most capital-efficient companies in the speciality chemicals sector. This superior return profile, combined with ROCE of 20.86%, indicates strong competitive advantages and pricing power. The company's ability to expand margins whilst growing volumes demonstrates operational leverage and effective management execution.

The company's balance sheet as of March 2025 reflected shareholder funds of ₹120.26 crores, comprising equity capital of ₹6.05 crores and reserves of ₹114.21 crores. Long-term debt stood at a modest ₹6.03 crores, resulting in a net debt-to-equity ratio of just 0.10, providing significant financial flexibility for future growth investments. Fixed assets totalled ₹32.98 crores, whilst investments stood at ₹41.97 crores, indicating a balanced asset allocation strategy.

Working capital management remained disciplined, with current assets of ₹75.48 crores comfortably exceeding current liabilities of ₹29.56 crores. Trade payables stood at ₹17.19 crores, suggesting healthy vendor relationships. The company's cash flow from operations for FY25 was ₹17.00 crores, though cash flow from investing activities of negative ₹28.00 crores reflected capital expenditure and investment activities undertaken during the year.

Industry Context: Speciality Chemicals Sector Dynamics

Narmada Gelatines operates in the speciality chemicals sector, specifically in the niche gelatine and ossein manufacturing segment. The company produces gelatine, ossein, di-calcium phosphate, and bone meal—products with applications across pharmaceuticals, food processing, photography, and animal nutrition industries. This diversified end-market exposure provides natural hedging against sector-specific downturns.

The speciality chemicals sector in India has witnessed mixed performance over the past year, with the sector index delivering returns of 9.28% over the trailing twelve months. However, Narmada Gelatines significantly outperformed this benchmark, delivering returns of 27.75% over the same period—an outperformance of 18.47 percentage points. This superior performance reflects company-specific improvements rather than sector-wide tailwinds.

Competitive Positioning

Narmada Gelatines benefits from its established presence in a niche segment with limited domestic competition. The company's focus on quality and consistency has helped it build long-term relationships with customers across pharmaceutical and food processing industries. The ongoing margin expansion suggests the company is successfully passing through raw material cost increases whilst maintaining volume growth—a testament to its pricing power and customer stickiness.

The gelatine industry is characterised by high entry barriers due to specialised manufacturing processes, quality certifications, and established customer relationships. Raw material availability—primarily bones and hides from the meat processing industry—represents a key input consideration. The company's location in Jabalpur, Madhya Pradesh, provides access to agricultural and meat processing hinterlands, offering potential sourcing advantages.

Peer Comparison: Valuation Discount Despite Superior Returns

A comparative analysis of Narmada Gelatines against its speciality chemicals peers reveals an intriguing valuation dynamic. Despite delivering superior ROE and strong growth momentum, the company trades at a significant discount to several peers on price-to-earnings (P/E) multiples, whilst commanding a premium on price-to-book (P/BV) ratios—a reflection of its superior return profile.

Company P/E (TTM) P/BV ROE (%) Debt/Equity Div Yield (%)
Narmada Gelatines 9.74 2.13 12.68 0.10 2.27
Aarti Surfactants 27.23 1.37 6.32 0.37 0.25
Dynemic Products 16.06 1.23 6.20 0.33
Indian Toners 9.39 1.11 12.13 -0.49 2.41
Diamines & Chemicals NA (Loss Making) 1.60 11.99 -0.16 0.39
Multibase India 23.26 2.90 8.07 -0.68

Narmada Gelatines trades at a P/E ratio of 9.74 times trailing twelve-month earnings, significantly below the peer group average of approximately 19 times (excluding loss-making companies). This valuation discount is particularly striking given that the company's ROE of 12.68% exceeds most peers, with only Indian Toners delivering comparable returns. The company's P/BV ratio of 2.13 times, whilst higher than most peers, appears justified given its superior return on equity—a classic quality premium.

The company's dividend yield of 2.27% ranks amongst the highest in the peer group, reflecting a shareholder-friendly capital allocation policy. With a dividend payout ratio of 35.16%, the company maintains a balanced approach between rewarding shareholders and retaining capital for growth. The company's debt-to-equity ratio of 0.10 is amongst the lowest in the peer set, providing significant financial flexibility.

"At 9.74 times earnings with ROE of 19.40%, Narmada Gelatines offers a compelling valuation proposition—a rare combination of quality and value in the speciality chemicals space."

Valuation Analysis: Attractive Entry Point for Quality Business

Narmada Gelatines' current valuation metrics present an attractive risk-reward proposition for investors seeking exposure to a quality speciality chemicals business. Trading at ₹439.70 as of May 25, 2026, the stock commands a market capitalisation of ₹243.00 crores, positioning it firmly in the micro-cap category. This small size offers both opportunities (potential for significant re-rating) and risks (liquidity constraints, limited analyst coverage).

The company's P/E ratio of 9.74 times stands at a significant discount to the broader speciality chemicals sector P/E of 42 times. This 77% discount appears excessive given the company's improving fundamentals, accelerating growth trajectory, and superior capital efficiency. The PEG ratio of 0.26 suggests the stock is significantly undervalued relative to its growth potential, with traditional valuation theory suggesting fair value PEG ratios closer to 1.0.

P/E Ratio (TTM)
9.74x
77% discount to sector
Price to Book Value
2.13x
Justified by 19.40% ROE
Dividend Yield
2.27%
Above peer average
PEG Ratio
0.26x
Significantly undervalued

The company's enterprise value-to-EBITDA (EV/EBITDA) multiple of 7.93 times appears reasonable for a growing speciality chemicals business, particularly one demonstrating consistent margin expansion. The EV/Sales ratio of 1.37 times reflects the company's improving profitability profile, whilst the EV/Capital Employed ratio of 2.03 times suggests efficient asset utilisation.

Book value per share stands at ₹198.77, implying the stock trades at 2.21 times book value. For a company generating ROE of 19.40%, this P/BV multiple appears attractive—traditional valuation frameworks suggest that companies earning returns above their cost of equity should trade at P/BV multiples above 1.0, with the premium justified by the spread between ROE and cost of equity.

Shareholding Pattern: Stable Promoter Base with Minimal Institutional Interest

Narmada Gelatines' shareholding structure reflects a stable, promoter-dominated ownership pattern with minimal institutional participation. Promoter holding has remained constant at 75.00% across the last five quarters, indicating strong promoter commitment and alignment with minority shareholders. Importantly, there is zero promoter pledging, eliminating concerns about financial stress or potential forced selling.

Shareholder Category Mar'26 Dec'25 Sep'25 Jun'25 QoQ Change
Promoter 75.00% 75.00% 75.00% 75.00% 0.00%
FII 0.00% 0.00% 0.00% 0.00% 0.00%
Mutual Funds 0.00% 0.00% 0.00% 0.00% 0.00%
Insurance 0.01% 0.01% 0.01% 0.01% 0.00%
Other DII 0.00% 0.00% 0.00% 0.00% 0.00%
Non-Institutional 24.99% 24.99% 24.99% 24.99% 0.00%

The key promoters include Pioneer Jellice India Private Limited (40.06%) and Ashok Matches and Timber Industries Private Limited (34.94%), both maintaining consistent stakes. The absence of institutional investors—with zero FII and mutual fund holdings—represents both a risk and an opportunity. On one hand, the lack of institutional interest may reflect the company's micro-cap status, limited liquidity, and minimal analyst coverage. On the other hand, it presents a significant discovery opportunity should institutional investors begin accumulating stakes as the company's operational performance continues improving.

The 24.99% non-institutional shareholding comprises retail investors and non-institutional entities. The stability of this holding across quarters suggests a loyal retail shareholder base, likely attracted by the company's consistent dividend payments and improving fundamentals. Total institutional holding stands at a negligible 0.01%, indicating the stock remains largely undiscovered by professional investors.

Stock Performance: Significant Outperformance Across Timeframes

Narmada Gelatines has delivered exceptional returns across multiple timeframes, significantly outperforming both the Sensex and its sector peers. The stock's recent momentum has been particularly impressive, with returns accelerating across short, medium, and long-term horizons.

Period Stock Return Sensex Return Alpha Sector Return
1 Week +13.63% +1.56% +12.07%
1 Month +13.50% -0.23% +13.73%
3 Months +23.62% -7.03% +30.65%
6 Months +28.34% -9.57% +37.91%
YTD +27.34% -10.25% +37.59%
1 Year +27.75% -6.40% +34.15% +9.28%
3 Years +46.86% +23.62% +23.24%
5 Years +145.64% +51.05% +94.59%

Over the trailing twelve months, Narmada Gelatines delivered returns of 27.75%, significantly outperforming the Sensex's negative 6.40% return—translating to an alpha of 34.15 percentage points. More impressively, the stock outperformed the speciality chemicals sector by 18.47 percentage points, delivering 27.75% returns versus the sector's 9.28% return.

The stock's momentum has accelerated in recent months, with three-month returns of 23.62% and six-month returns of 28.34%. Year-to-date performance stands at 27.34%, reflecting the strong operational performance and improving investor sentiment. The stock currently trades above all key moving averages—5-day (₹407.45), 20-day (₹408.73), 50-day (₹379.32), 100-day (₹369.02), and 200-day (₹362.39)—indicating strong technical momentum.

Risk Consideration: High Volatility Profile

Investors should note that Narmada Gelatines exhibits high volatility, with annualised volatility of 34.51% significantly exceeding the Sensex's 13.00%. The stock's beta of 1.50 indicates it is 50% more volatile than the broader market. Whilst this volatility has worked in favour of investors during the recent rally, it also implies higher downside risk during market corrections. The stock's risk-adjusted return (Sharpe ratio) remains positive at 0.80, suggesting returns have adequately compensated for the elevated risk.

Investment Thesis: Quality Business at Reasonable Valuation

Narmada Gelatines presents a compelling investment thesis built on improving fundamentals, superior capital efficiency, and attractive valuation. The company's proprietary investment score of 84 out of 100 reflects strong performance across multiple parameters, justifying a "Strong Buy" rating.

Valuation Grade
Fair
Attractive at current levels
Quality Assessment
Good
Strong fundamentals
Financial Trend
Positive
Improving trajectory
Technical Trend
Bullish
Strong momentum

The company's quality assessment of "Good" reflects its strong long-term financial performance, with five-year sales CAGR of 9.54% and EBIT growth of 36.35%. The absence of promoter pledging, consistent dividend payments, and strong balance sheet with minimal leverage (debt-to-equity of 0.10) further support the quality thesis. Average ROCE of 15.29% and improving trend (latest ROCE of 20.86%) demonstrate management's ability to deploy capital efficiently.

From a valuation perspective, the stock's current rating of "Fair" suggests reasonable pricing given recent performance improvements. However, the significant discount to sector multiples (P/E of 9.74x versus sector P/E of 42x) and the extremely low PEG ratio of 0.26 indicate potential for multiple expansion as the company's improved performance gains broader recognition.

Technical indicators uniformly support the bullish thesis, with the stock in a confirmed uptrend since April 17, 2026. All key technical indicators—MACD, Bollinger Bands, and KST—flash bullish signals on both weekly and monthly timeframes. The stock's position above all major moving averages provides technical support for the current rally.

Key Strengths & Risk Factors

KEY STRENGTHS

  • Exceptional Margin Expansion: Operating margins expanded 730 bps YoY to 22.30%, demonstrating strong pricing power and operational efficiency
  • Superior Capital Efficiency: ROE of 19.40% and ROCE of 20.86% significantly exceed peer averages, indicating competitive advantages
  • Robust Growth Momentum: Four consecutive quarters of accelerating growth with Q4 FY26 revenue up 23.97% YoY
  • Strong Balance Sheet: Minimal leverage (debt-to-equity 0.10) and no promoter pledging provide financial flexibility
  • Attractive Valuation: Trading at 9.74x P/E with PEG ratio of 0.26, offering significant upside potential
  • Consistent Dividend Payer: Dividend yield of 2.27% with sustainable payout ratio of 35.16%
  • Technical Momentum: Strong bullish trend with stock above all key moving averages

KEY CONCERNS

  • Micro-Cap Risks: Small market cap of ₹243 crores limits liquidity and increases volatility
  • Zero Institutional Interest: Absence of FII and mutual fund holdings raises discovery risk
  • High Volatility: Beta of 1.50 and volatility of 34.51% imply significant price swings
  • Limited Analyst Coverage: Lack of research coverage may delay broader market recognition
  • Raw Material Dependency: Reliance on meat processing by-products exposes company to agricultural sector dynamics
  • Concentrated Ownership: 75% promoter holding limits free float and may impact liquidity
  • Sustainability of Margins: Ability to maintain 22%+ operating margins needs monitoring

Outlook: Key Monitoring Points

POSITIVE CATALYSTS

  • ✓ Sustained margin expansion above 20% levels
  • ✓ Institutional investor discovery and stake building
  • ✓ Continued double-digit revenue growth trajectory
  • ✓ Multiple expansion towards sector averages
  • ✓ Capacity expansion announcements

RED FLAGS TO WATCH

  • ⚠ Margin compression below 18% levels
  • ⚠ Sequential revenue decline for two consecutive quarters
  • ⚠ Increase in debt levels or deteriorating coverage ratios
  • ⚠ Promoter stake reduction or pledging
  • ⚠ Working capital deterioration

Looking ahead, the key question for investors is whether Narmada Gelatines can sustain its impressive margin expansion and growth momentum. The company's ability to maintain operating margins above 20% whilst continuing to grow volumes will be critical. Any signs of margin pressure due to raw material cost inflation or competitive intensity would warrant close monitoring.

The potential for institutional discovery represents a significant catalyst. With zero FII and mutual fund holdings currently, even modest institutional buying could drive substantial re-rating given the limited free float. The company's improving fundamentals, attractive valuation, and strong technical momentum position it well for broader market recognition.

The Verdict: Compelling Opportunity for Growth-Oriented Investors

STRONG BUY

Score: 84/100

For Fresh Investors: Narmada Gelatines represents an excellent entry opportunity for investors seeking exposure to a quality speciality chemicals business at attractive valuations. The combination of accelerating growth (24% revenue growth, 69% profit growth), expanding margins (22.30% operating margin), superior capital efficiency (19.40% ROE), and reasonable valuation (9.74x P/E, 0.26 PEG) creates a compelling risk-reward proposition. The micro-cap nature and high volatility require position sizing discipline, but the fundamental trajectory justifies accumulation.

For Existing Holders: Continue holding with conviction. The Q4 FY26 results validate the operational turnaround thesis and suggest the margin expansion story has further room to run. The technical breakout above ₹400 levels, combined with improving fundamentals, supports the bullish case. Consider adding on any dips towards the ₹380-400 zone (20-day and 50-day moving average support).

Fair Value Estimate: ₹550-600 (25-36% upside from current levels of ₹439.70), based on 12-15x P/E multiple on FY27 estimated earnings, reflecting gradual convergence towards sector multiples as operational performance gains broader recognition.

Note- ROCE= (EBIT - Other income)/(Capital Employed - Cash - Current Investments)

⚠️ Investment Disclaimer

This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions. Past performance does not guarantee future results. The micro-cap nature of Narmada Gelatines implies higher risk and volatility compared to large-cap stocks.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News